Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

被引:1827
作者
Basch, Ethan [1 ,2 ]
Deal, Allison M. [2 ]
Kris, Mark G. [1 ]
Scher, Howard I. [1 ]
Hudis, Clifford A. [1 ]
Sabbatini, Paul [1 ]
Rogak, Lauren [1 ]
Bennett, Antonia V. [2 ]
Dueck, Amylou C. [3 ]
Atkinson, Thomas M. [1 ]
Chou, Joanne F. [1 ]
Dulko, Dorothy [1 ]
Sit, Laura [1 ]
Barz, Allison [4 ]
Novotny, Paul [5 ]
Fruscione, Michael [1 ]
Sloan, Jeff A. [5 ]
Schrag, Deborah [1 ,6 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Mayo Clin, Scottsdale, AZ USA
[4] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[5] Mayo Clin, Rochester, MN USA
[6] Dana Farber Harvard Canc Ctr, Boston, MA USA
关键词
QUALITY-OF-LIFE; CLINICAL-PRACTICE; CARE; IMPACT; COMMUNICATION; IMPROVEMENT; PROVIDERS; SURVIVAL; SCORES; PAIN;
D O I
10.1200/JCO.2015.63.0830
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose There is growing interest to enhance symptom monitoring during routine cancer care using patient-reported outcomes, but evidence of impact on clinical outcomes is limited. Methods We randomly assigned patients receiving routine outpatient chemotherapy for advanced solid tumors at Memorial Sloan Kettering Cancer Center to report 12 common symptoms via tablet computers or to receive usual care consisting of symptom monitoring at the discretion of clinicians. Those with home computers received weekly e-mail prompts to report between visits. Treating physicians received symptom printouts at visits, and nurses received e-mail alerts when participants reported severe or worsening symptoms. The primary outcome was change in health-related quality of life (HRQL) at 6 months compared with baseline, measured by the EuroQol EQ-5D Index. Secondary endpoints included emergency room (ER) visits, hospitalizations, and survival. Results Among 766 patients allocated, HRQL improved among more participants in the intervention group than usual care (34% v 18%) and worsened among fewer (38% v 53%; P < .001). Overall, mean HRQL declined by less in the intervention group than usual care (1.4-v 7.1-point drop; P,.001). Patients receiving intervention were less frequently admitted to the ER (34% v 41%; P = .02) or hospitalized (45% v 49%; P = .08) and remained on chemotherapy longer (mean, 8.2 v 6.3 months; P = .002). Although 75% of the intervention group was alive at 1 year, 69% with usual care survived the year (P = .05), with differences also seen in quality-adjusted survival (mean of 8.7 v. 8.0 months; P = .004). Benefits were greater for participants lacking prior computer experience. Most patients receiving intervention (63%) reported severe symptoms during the study. Nurses frequently initiated clinical actions in response to e-mail alerts. Conclusion Clinical benefits were associated with symptom self-reporting during cancer care. (C) 2015 by American Society of Clinical Oncology
引用
收藏
页码:557 / +
页数:11
相关论文
共 37 条
[1]  
Agency for Healthcare Research and Quality, 2012, US VAL EUROQOL EQ 5D
[2]   Reliability of adverse symptom event reporting by clinicians [J].
Atkinson, Thomas M. ;
Li, Yuelin ;
Coffey, Charles W. ;
Sit, Laura ;
Shaw, Mary ;
Lavene, Dawn ;
Bennett, Antonia V. ;
Fruscione, Mike ;
Rogak, Lauren ;
Hay, Jennifer ;
Goenen, Mithat ;
Schrag, Deborah ;
Basch, Ethan .
QUALITY OF LIFE RESEARCH, 2012, 21 (07) :1159-1164
[3]   Patient online self-reporting of toxicity symptoms during chemotherapy [J].
Basch, E ;
Artz, D ;
Dulko, D ;
Scher, K ;
Sabbatini, P ;
Hensley, M ;
Mitra, N ;
Speakman, J ;
McCabe, M ;
Schrag, D .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3552-3561
[4]   Use of information resources by patients with cancer and their companions [J].
Basch, EM ;
Thaler, HT ;
Shi, W ;
Yakren, S ;
Schrag, D .
CANCER, 2004, 100 (11) :2476-2483
[5]   Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy [J].
Basch, Ethan ;
Iasonos, Alexia ;
Barz, Allison ;
Culkin, Ann ;
Kris, Mark G. ;
Artz, David ;
Fearn, Paul ;
Speakman, John ;
Farquhar, Rena ;
Scher, Howard I. ;
McCabe, Mary ;
Schrag, Deborah .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) :5374-5380
[6]   Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities [J].
Basch, Ethan ;
Artz, David ;
Iasonos, Alexia ;
Speakman, John ;
Shannon, Kevin ;
Lin, Kai ;
Pun, Charmaine ;
Yong, Henry ;
Paul, Fearn ;
Barz, Allison ;
Scher, Howard I. ;
McCabe, Mary ;
Schrag, Deborah .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2007, 14 (03) :264-268
[7]   Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology [J].
Basch, Ethan ;
Abernethy, Amy P. ;
Mullins, C. Daniel ;
Reeve, Bryce B. ;
Smith, Mary Lou ;
Coons, Stephen Joel ;
Sloan, Jeff ;
Wenzel, Keith ;
Chauhan, Cynthia ;
Eppard, Wayland ;
Frank, Elizabeth S. ;
Lipscomb, Joseph ;
Raymond, Stephen A. ;
Spencer, Merianne ;
Tunis, Sean .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34) :4249-4255
[8]   Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes [J].
Basch, Ethan ;
Jia, Xiaoyu ;
Heller, Glenn ;
Barz, Allison ;
Sit, Laura ;
Fruscione, Michael ;
Appawu, Mark ;
Iasonos, Alexia ;
Atkinson, Thomas ;
Goldfarb, Shari ;
Culkin, Ann ;
Kris, Mark G. ;
Schrag, Deborah .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (23) :1624-1632
[9]   Electronic patient-reported outcome systems in oncology clinical practice [J].
不详 .
CA-A CANCER JOURNAL FOR CLINICIANS, 2012, 62 (05) :336-347
[10]   Enhancing Patient-Provider Communication With the Electronic Self-Report Assessment for Cancer: A Randomized Trial [J].
Berry, Donna L. ;
Blumenstein, Brent A. ;
Halpenny, Barbara ;
Wolpin, Seth ;
Fann, Jesse R. ;
Austin-Seymour, Mary ;
Bush, Nigel ;
Karras, Bryant T. ;
Lober, William B. ;
McCorkle, Ruth .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (08) :1029-1035